Overview
Isolated rare lymphatic malformation (also known as lymphangioma or cystic hygroma when occurring in specific locations) is a congenital malformation of the lymphatic system characterized by abnormal development of lymphatic vessels and spaces. These malformations consist of dilated lymphatic channels that form cystic or cavernous masses filled with lymphatic fluid. They can occur anywhere in the body but most commonly affect the head, neck, axilla, and trunk. Lymphatic malformations are classified based on the size of the cystic spaces into macrocystic (large cysts), microcystic (small cysts), or mixed types. Clinical features vary depending on the location and size of the malformation. Patients may present with soft, compressible masses that can enlarge over time, particularly during infections or with intralesional bleeding. Complications include pain, swelling, recurrent infections (cellulitis or lymphangitis), functional impairment of nearby structures (such as airway obstruction in cervicofacial lesions), disfigurement, and oozing of lymphatic fluid. Some lymphatic malformations are detected prenatally or at birth, while others become apparent during infancy or childhood. Rapid enlargement can occur following upper respiratory infections or trauma. Treatment depends on the type, size, and location of the malformation. Options include observation for small asymptomatic lesions, sclerotherapy (injection of sclerosing agents such as doxycycline, bleomycin, or OK-432 into the cystic spaces), and surgical excision for symptomatic or functionally significant lesions. Complete surgical removal can be challenging due to the infiltrative nature of these malformations, and recurrence is common. More recently, targeted medical therapies including sirolimus (an mTOR inhibitor) have shown promise in managing complex or refractory lymphatic malformations by reducing their size and associated symptoms. A multidisciplinary approach involving vascular anomaly specialists is recommended for optimal management.
Also known as:
Sporadic
Usually appears on its own, not inherited from a parent
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Isolated rare lymphatic malformation.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Isolated rare lymphatic malformation at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
1 resourcesLYMPHOSEEK
Cardinal Health 414, LLC
LYMPHOSEEK — Contact Cardinal Health 414, LLC
Travel Grants
No travel grants are currently matched to Isolated rare lymphatic malformation.
Community
No community posts yet. Be the first to share your experience with Isolated rare lymphatic malformation.
Start the conversation →Latest news about Isolated rare lymphatic malformation
Disease timeline:
New recruiting trial: Institution of an Italian Registry and Biobank for Biological Sample Collection
A new clinical trial is recruiting patients for Isolated rare lymphatic malformation
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Isolated rare lymphatic malformation
What is Isolated rare lymphatic malformation?
Isolated rare lymphatic malformation (also known as lymphangioma or cystic hygroma when occurring in specific locations) is a congenital malformation of the lymphatic system characterized by abnormal development of lymphatic vessels and spaces. These malformations consist of dilated lymphatic channels that form cystic or cavernous masses filled with lymphatic fluid. They can occur anywhere in the body but most commonly affect the head, neck, axilla, and trunk. Lymphatic malformations are classified based on the size of the cystic spaces into macrocystic (large cysts), microcystic (small cysts)
How is Isolated rare lymphatic malformation inherited?
Isolated rare lymphatic malformation follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Isolated rare lymphatic malformation typically begin?
Typical onset of Isolated rare lymphatic malformation is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Isolated rare lymphatic malformation?
2 specialists and care centers treating Isolated rare lymphatic malformation are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.
What treatment and support options exist for Isolated rare lymphatic malformation?
1 patient support program are currently tracked on UniteRare for Isolated rare lymphatic malformation. See the treatments and support programs sections for copay assistance, eligibility, and contact details.